8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.40%
Revenue growth under 50% of 9843.T's 4.85%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.40%
Gross profit growth at 75-90% of 9843.T's 4.11%. Bill Ackman would demand operational improvements to match competitor gains.
-2.91%
Negative EBIT growth while 9843.T is at 33.89%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
4.04%
Operating income growth under 50% of 9843.T's 33.79%. Michael Burry would be concerned about deeper cost or sales issues.
-15.54%
Negative net income growth while 9843.T stands at 25.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.54%
Negative EPS growth while 9843.T is at 25.94%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.54%
Negative diluted EPS growth while 9843.T is at 25.64%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 9843.T's 0.07%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 9843.T's 0.24%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.57%
10Y revenue/share CAGR under 50% of 9843.T's 122.27%. Michael Burry would suspect a lasting competitive disadvantage.
57.04%
5Y revenue/share CAGR 1.25-1.5x 9843.T's 39.97%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
29.96%
3Y revenue/share CAGR 1.25-1.5x 9843.T's 20.39%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.45%
Net income/share CAGR at 50-75% of 9843.T's 134.61%. Martin Whitman might question if the firm’s product or cost base lags behind.
86.04%
5Y net income/share CAGR 1.25-1.5x 9843.T's 66.35%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
9.43%
3Y net income/share CAGR 50-75% of 9843.T's 18.55%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
130.07%
5Y equity/share CAGR 1.25-1.5x 9843.T's 97.61%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
62.57%
3Y equity/share CAGR 1.25-1.5x 9843.T's 49.20%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.20%
Firm’s AR is declining while 9843.T shows 28.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.35%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.06%
Asset growth well under 50% of 9843.T's 1.09%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.14%
Similar to 9843.T's 3.19%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-41.08%
We’re deleveraging while 9843.T stands at 42.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
96.39%
SG&A growth well above 9843.T's 15.87%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.